关注
Dordi Lea
Dordi Lea
Overlege i Patologi, Stavanger Universitetssjukehus
在 sus.no 的电子邮件经过验证
标题
引用次数
引用次数
年份
Accuracy of TNM staging in colorectal cancer: a review of current culprits, the modern role of morphology and stepping-stones for improvements in the molecular era
D Lea, S Håland, HR Hagland, K Søreide
Scandinavian journal of gastroenterology 49 (10), 1153-1163, 2014
842014
Norwegian medical students’ attitudes towards the pharmaceutical industry
D Lea, O Spigset, L Slørdal
European journal of clinical pharmacology 66, 727-733, 2010
492010
Elevated microsatellite alterations at selected tetranucleotides in early‐stage colorectal cancers with and without high‐frequency microsatellite instability: Same, same but …
MM Watson, D Lea, E Rewcastle, HR Hagland, K Søreide
Cancer medicine 5 (7), 1580-1587, 2016
302016
Correlation of blood T-cells to intratumoural density and location of CD3+ and CD8+ T-cells in colorectal cancer
HR Hagland, D Lea, MM Watson, K Søreide
Anticancer Research 37 (2), 675-683, 2017
252017
Assessment of clinically related outcomes and biomarker analysis for translational integration in colorectal cancer (ACROBATICC): study protocol for a population-based …
K Søreide, MM Watson, D Lea, O Nordgård, JA Søreide, HR Hagland, ...
Journal of translational medicine 14, 1-9, 2016
232016
A template to quantify the location and density of CD3+ and CD8+ tumor-infiltrating lymphocytes in colon cancer by digital pathology on whole slides for an objective …
D Lea, M Watson, I Skaland, HR Hagland, M Lillesand, E Gudlaugsson, ...
Cancer Immunology, Immunotherapy 70, 2049-2057, 2021
162021
Digital image analysis of the proliferation markers Ki67 and phosphohistone H3 in gastroenteropancreatic neuroendocrine neoplasms: accuracy of grading compared with routine …
D Lea, EG Gudlaugsson, I Skaland, M Lillesand, K Søreide, JA Søreide
Applied Immunohistochemistry & Molecular Morphology 29 (7), 499-505, 2021
152021
Prevalence of PD-L1 expression is associated with EMAST, density of peritumoral T-cells and recurrence-free survival in operable non-metastatic colorectal cancer
MM Watson, D Lea, E Gudlaugsson, I Skaland, HR Hagland, K Søreide
Cancer Immunology, Immunotherapy 69, 1627-1637, 2020
152020
Elevated microsatellite alterations at selected tetranucleotides (EMAST) in colorectal cancer is associated with an elderly, frail phenotype and improved recurrence-free survival
MM Watson, A Kanani, D Lea, RB Khajavi, JA Søreide, H Kørner, ...
Annals of surgical oncology 27, 1058-1067, 2020
142020
Elevated microsatellite alterations at selected tetranucleotides (EMAST) is not attributed to MSH3 loss in stage I-III colon cancer: an automated, digitalized assessment by …
MM Watson, D Lea, HR Hagland, K Søreide
Translational Oncology 12 (12), 1583-1588, 2019
92019
The overriding role of surgery and tumor grade for long‐term survival in patients with gastroenteropancreatic neuroendocrine neoplasms: A population‐based cohort study
JA Søreide, JT Kvaløy, D Lea, OM Sandvik, M Al‐Saiddi, TM Haslerud, ...
Cancer Reports 5 (2), e1462, 2022
72022
Clinical trials of neoadjuvant immune checkpoint inhibitors for early-stage operable colon and rectal cancer
T Veen, A Kanani, D Lea, K Søreide
Cancer Immunology, Immunotherapy 72 (10), 3135-3147, 2023
52023
Histopathological growth pattern in colorectal liver metastasis and the tumor immune microenvironment
C Zaharia, T Veen, D Lea, A Kanani, M Alexeeva, K Søreide
Cancers 15 (1), 181, 2022
52022
A case of Ménétriere´ s disease treated with the monoclonal antibody cetuximab
A Carlsen, TB Grimstad, LN Karlsen, OJ Greve, KB Norheim, D Lea
Clinical Journal of Gastroenterology 12, 562-565, 2019
42019
The gastrinoma saga before Zollinger and Ellison: the Strøm case revisited
JA Søreide, D Lea
Annals of surgery 270 (2), e19-e21, 2019
42019
Programmed death ligand-1 (PD-L1) clone 22C3 expression in resected colorectal cancer as companion diagnostics for immune checkpoint inhibitor therapy: A comparison study and …
D Lea, C Zaharia, K Søreide
Cancer Treatment and Research Communications 38, 100788, 2024
22024
Neoadjuvant immunotherapy in colorectal cancer beyond immune checkpoint inhibitors: emerging from bench to bedside.
A Kanani, T Veen, M Alexeeva, D Lea, K Søreide
Minerva Surgery, 2023
22023
Fremtidens patologi er digital
D Lea, L Hatleskog
Tidsskrift for Den norske legeforening, 2022
22022
Fatal adverse event with dabigatran in elderly patient with reduced kidney function
SM Havig, D Lea, M Krpo, RM Skari, I Gustavsen, G Høiseth
Basic & Clinical Pharmacology & Toxicology 123 (2), 221-226, 2018
22018
Correlation of circulating T-cells in pre-operative blood to intratumoral density and location of CD3+ and CD8+ T-cells in colorectal cancer: a potential for an immunoscore by …
HR Hagland, D Lea, MMC Watson, K Søreide
European Journal of Cancer 1 (72), S49-S50, 2017
22017
系统目前无法执行此操作,请稍后再试。
文章 1–20